Article info

Download PDFPDF

How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Free

Authors

  1. Correspondence to Dr Ioannis Parodis, Division of Rheumatology, Department of Medicine, Karolinska Institutet, 171 77 Solna, Sweden; ioannis.parodis{at}ki.se
View Full Text

Citation

Parodis I, Nikpour M
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

Publication history

  • Received April 30, 2019
  • Accepted May 3, 2019
  • First published May 10, 2019.
Online issue publication 
June 17, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.